Clinical Trial of High Flow Nasal Cannula

CRO Ltd. initiated a validation clinical trial of HF-ONE, a high flow nasal cannula manufactured in Bangladesh during COVID-19 pandemic. Sponsor of the clinical trial was Renata Ltd., Bangladesh. The study was discontinued by the sponsor as the COVID-19 as pandemic came to an end.